1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)

Technology appraisal [TA351] Published date: 22 July 2015

  • Guidance
  • Tools and resources
  • History

Documents

A list of downloadable documents created during development.

Coronary heart disease - cangrelor: draft scope for consultation (pre-referral) - November 2013

  • Coronary heart disease - cangrelor: draft scope for consultation (pre-referral) - November 2013 13 May 2014   117.96 KB

Coronary heart disease - cangrelor: provisional matrix (pre-referral) - November 2013

  • Coronary heart disease - cangrelor: provisional matrix (pre-referral) - November 2013 13 May 2014   43.78 KB
NICE
  • About NICE
  • Into practice
  • News
  • Contact us
  • Leave feedback
  • Jobs
  • Newsletters and alerts
  • Blog
  • Twitter
  • YouTube
  •   Facebook
  • LinkedIn

Explore

  • Guidance
  • Pathways
  • Standards and indicators
  • Evidence search
  • BNF
  • BNFC
  • Clinical knowledge summaries
  • Journals and databases

Reusing our content

  • Reuse information
  • NICE UK Open Content Licence

Guidance app

  • Android
  • iOS

Get involved

  • Register as a stakeholder
  • Citizens council
  • Consultations
  • Fellows and scholars
  • Join a committee
  • Meetings in public
  • Student champions
  • Tenders
  • Public involvement
  • Accessibility
  • Freedom of information
  • Syndication services
  • Glossary
  • Terms and conditions
  • Privacy notice

© NICE [year]. All rights reserved. Subject to Notice of rights.